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The human Tap protein has been proposed to mediate Mason Pfizer monkey virus constitutive transport element
(CTE)-dependent nuclear RNA export and may also play a role in global mRNA export. Here, we have used in vivo assays,
in both yeast and human cells, together with in vitro assays, to further characterize the RNA binding properties of Tap, which
has been proposed to contain a novel leucine-rich RNA binding motif. Using the yeast three hybrid assay, we selected RNA
molecules that retain Tap binding activity from a pool of randomized CTE sequences. The recovered RNA sequences differed
only minimally from the wild-type CTE yet all displayed lower affinity for Tap both in vivo and in vitro. Analysis of the RNA
export activity of the recovered CTE variants revealed that Tap affinity was highly predictive of CTE biological activity.
Together, these observations provide additional evidence supporting the identification of Tap as the direct cofactor for CTE
function and demonstrate that RNA binding by Tap is highly sequence specific. © 1999 Academic Press
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cINTRODUCTION
While considerable progress has recently been made
n identifying and dissecting the various nuclear export
athways used by noncoding RNA molecules, the path-
ay utilized by cellular mRNAs remains poorly under-
tood (reviewed by Izaurralde and Adam, 1998; Stutz and
osbash, 1998). At present, there are at least two possi-
le candidates as mediators of mRNA export in human
ells. The first of these is a highly expressed group of
roteins termed the heterogeneous nuclear ribonucleo-
roteins (hnRNPs), of which the prototype is hnRNPA1.
he hnRNPs are known to bind to mRNAs in the nucleus
nd some, but not all, hnRNPs then accompany these
RNAs from the nucleus to the cytoplasm (Pinol-Roma
nd Dreyfuss, 1992). This protein nucleocytoplasmic
huttling is not passive, in that several hnRNPs have
een shown to contain a nuclear export signal (NES) that
unctions independently of both RNA synthesis and RNA
inding (Michael et al., 1995, 1997). The NES present in
nRNPA1, termed M9, also acts as a nuclear localization
ignal (NLS) and these two activities cannot be muta-
ionally segregated (Michael et al., 1995; Bogerd et al.,
999). Nevertheless, it appears unlikely that the trans-
ortin nuclear import factor, which is known to mediate
9 NLS function (Pollard et al., 1996; Fridell et al., 1997),
s also the mediator of M9 NES activity (Izaurralde et al.,
997b; Bogerd et al., 1999). While the target of the M9
1 To whom correspondence and reprint requests should be ad-
ressed at Howard Hughes Medical Institute, Department of Genetics,
uke University Medical Center, Box 3025, Durham, NC 27710. Fax:e919) 681-8979. E-mail: culle002@mc.duke.edu.
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200ES is therefore presently unknown, its importance for
RNA export is suggested by the finding that nuclear
njection of high levels of wild-type hnRNPA1, but not of
n M9 mutant, can specifically block mRNA export (Izaur-
alde et al., 1997a).
A second candidate human mRNA export factor is Tap,
protein that has been proposed (Gru¨ter et al., 1998) to
ediate the sequence-specific nuclear export of RNAs
earing the constitutive transport element (CTE) origi-
ally described in Mason–Pfizer monkey virus (MPMV)
Bray et al., 1994). A role for Tap in general mRNA export
s suggested by the finding that the inhibition of both
TE-dependent and general mRNA export that is in-
uced by nuclear injection of high levels of the CTE
Pasquinelli et al., 1997; Saavedre et al., 1997) can be
escued by injection of recombinant Tap protein (Gru¨ter
t al., 1998). A role for human Tap in nuclear mRNA
xport is also implied by the observation that the yeast
omolog of Tap, termed Mex67p, is critical for mRNA
xport in yeast cells. Importantly, Mex67p has been
ound to be associated with bulk yeast poly(A)1 RNA,
hus suggesting that Mex67p might bridge the interac-
ion between mRNAs and a nuclear export factor (Segref
t al., 1997; Santos-Rosa et al., 1998). Consistent with this
ypothesis, Tap has been shown to contain a novel
eucine-rich RNA binding domain (Braun et al., 1999) and
lso a novel type of NES that is critical for Tap function
Kang and Cullen, 1999). However, the target for this NES
emains to be defined.
Although Tap has been shown to bind the CTE spe-
ifically both in vitro and in vivo (Gru¨ter et al., 1998; Braun
t al., 1999; Kang and Cullen, 1999), the RNA binding
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201RNA BINDING SPECIFICITY OF HUMAN Tappecificity of Tap has remained largely undefined and it
as remained unclear whether Tap has both specific and
onspecific RNA binding properties. In this manuscript,
e have attempted to shed light on the RNA binding
roperties of Tap by randomizing bases in the critical
TE loop sequence that serves as the Tap binding site
nd then using the yeast three hybrid protein:RNA inter-
ction assay (Sengupta et al., 1996) to select for RNAs
hat retain Tap binding. Interestingly, while we were able
o identify several CTE variants that retained Tap binding,
he wild-type CTE sequence clearly bound Tap with the
ighest affinity. Importantly, the ability of these CTE vari-
nts to bind Tap was found to closely correlate with their
bility to support nuclear RNA export. Together, these
ata therefore shed light on the RNA binding properties
f the novel leucine-rich RNA binding domain present in
ap and provide an additional line of evidence support-
ng the identification of Tap as the CTE-specific nuclear
NA export factor.
RESULTS
The MPMV CTE nuclear RNA export signal has been
hown to form an extended RNA stem–loop structure
earing two identical 12-nucleotide (nt) internal loops,
esignated loop A and loop B, that are oriented at 180°
elative to one another (Fig. 1) (Tabernero et al., 1996;
rnst et al., 1997). The integrity of both of these loops
s critical for CTE function while flanking helical se-
uences appear to serve a primarily structural role.
oth in vitro data and in vivo data obtained in mam-
alian cells indicate that a single CTE loop is suffi-
ient for specific binding by Tap, a result that has yet
o be reconciled with the observation that two loops
re required for CTE activity in primate cells (Tabern-
ro et al., 1996; Ernst et al., 1997; Gru¨ter et al., 1998;
ang and Cullen, 1999).
ap binds the CTE specifically in the yeast three
ybrid assay
While the interaction between the CTE and Tap has
een shown to be specific, the nucleotides involved in
NA recognition by Tap have remained undefined. Pre-
iously, we have used a strategy of sequence random-
zation followed by genetic selection in yeast cells to
etermine the protein sequence determinants required
or the biological activity of both leucine-rich NESs and
he M9 NLS/NES (Bogerd et al., 1996, 1999), and we have
sed a similar strategy to define the DNA sequence
equirements for DNA binding by the Bel-1 transcrip-
ional activator (Kang and Cullen, 1998). We therefore
ecided to use a similar strategy to more clearly define
he RNA sequence requirements for Tap binding and to
erive a set of CTE variants that retained partial Tap
inding activity. Because this strategy requires the abilityo genetically select positive clones from a background tf negative clones in a yeast genetic screen, we first
sked whether Tap would specifically bind to the MPMV
TE in the yeast three hybrid assay. As shown in Table 1,
he full-length Tap protein indeed proved able to effec-
FIG. 1. Predicted structure of the MPMV CTE RNA element. The CTE
as been shown to fold into a helical RNA structure that presents two
dentical internal RNA loops, designated loop A and loop B, that serve
s specific protein binding sites. The full-length MPMV CTE used in this
anuscript, and the extent of the “1/2 CTE” RNA sequences used in the
east and mammalian RNA:protein binding assays, is shown, as is the
ocation of selected point mutants and of the seven nucleotides in loop
that were subjected to randomization. Sequence coordinates refer to
he sequence of the full-length MPMV genome and are as defined by
rnst et al. (1997).ively bind to the full-length CTE but not to an antisense
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202 KANG ET AL.TE (CTE AS) or to such irrelevant structured RNA se-
uences as the human immunodeficiency virus type 1
HIV-1) TAR element and a human iron response element
IRE).
Introduction of the M1 point mutant (Fig. 1) into
ither loop A (M1-A) or loop B (M1-B), either of which
s sufficient to block CTE function (Kang and Cullen,
999), reduced but did not prevent CTE binding by Tap
Table 1). However, introduction of the M1 mutation
nto both internal loops (M1-AB) blocked CTE binding
y Tap. Mutation of the terminal CTE loop (M-L), which
oes not prevent CTE function (Tabernero et al., 1996
nd see below), had little effect on Tap binding to the
omplete CTE (Table 1). To confirm that Tap could
ndeed bind a single CTE loop, we next tested the
pical half of the CTE (Fig. 1) in the three hybrid assay.
s shown in Table 1, the 1/2 CTE indeed bound Tap
ffectively. Introduction of the M1 mutation into the
ingle remaining internal CTE loop blocked Tap bind-
ng while mutation of the terminal loop (M-L) had only
modest effect. We therefore conclude that Tap can
ind the CTE specifically in the yeast three hybrid
ssay and that this interaction is dependent on the
TABLE 1
Interaction of Tap with the MPMV CTE in Yeast Cells
b-gal activity (mOD/ml)
VP16-Tap VP16
IRE ,4 ,4
TAR ,4 ,4
CTE
CTE 602 11
CTE AS ,4 ,4
M1-A 406 ,4
M1-B 148 ,4
M1-AB ,4 ,4
M-L 597 ,4
1/2 CTE
1/2 CTE 1691 21
M-L 509 15
M1 ,4 ,4
Note. The ability of human Tap to bind to wild-type and mutant forms
f the MPMV CTE was analyzed using the yeast three hybrid RNA:
rotein interaction assay. The indicated levels of b-gal activity, induced
pon interaction of a fusion protein consisting of the VP16 activation
omain fused to the full-length Tap protein with the indicated RNA
argets, represent the average of three independent experiments. Con-
rols included the HIV-1 TAR element, a human iron response element
IRE), and the anti-sense CTE (CTE AS). The single nucleotide M1
utation, which inactivates CTE function, is shown in Fig. 1 and was
ntroduced into loop A (M1-A), loop B (M1-B), or both CTE loops
M1-AB). The terminal CTE loop mutation M-L, which does not block
TE function, is also shown in Fig. 1.resence of at least one intact CTE internal loop. melection of CTE variants that retain tap binding
Having shown that the 1/2 CTE indeed interacted
vidly and specifically with Tap in the yeast three hybrid
ssay, we next randomized the seven nucleotides that
orm the 59 part of CTE loop B (Fig. 1) in the 1/2 CTE
ontext and then selected for CTE variants that retained
he ability to bind Tap in the yeast three hybrid assay, as
hown by detection of b-galactosidase (b-gal) indicator
nzyme expressing yeast colonies by in situ analysis.
As shown in Table 2, this randomization led to the
ecovery of five CTE sequences that proved able to
pecifically interact with Tap, all of which were recovered
wo or more times. In addition to the wild-type CTE
equence, we recovered four CTE variants (V1 to V4,
able 2) that showed a level of Tap binding that varied
etween 69 and 25% of that seen with the wild-type CTE,
hus strongly suggesting that the wild-type CTE has the
ptimal RNA sequence for Tap binding. Variants V1 to V3
ere found to differ from the wild-type sequence by only
ne nucleotide, while V4 differed at four of seven posi-
ions (Table 2). In addition to the CTE variants that bound
ap, we also repeatedly (13 times) recovered a strongly
-gal-positive variant of the CTE that, however, was
qually positive both in the absence and presence of the
TABLE 2
Interaction of Tap and CTE Mutants and Selected CTE Variants
in Yeast Cells
Clone Sequence
Relative b-gal activity
1VP16-Tap 1VP16
T(38) UAAGACA 100 ,1
1(36) UAAAACA 33 ,1
2(35) UAAGCCA 69 ,1
3(32) UAGGACA 25 ,1
4(32) GGAAAAA 50 #1
5(313) GAUGGCA 241 273
2 UAAAGUA ,1 #1
3 UAACACA ,1 #1
4 UAAGGCA 16 ,1
5 UAUGACA 9 ,1
Note. Seven nucleotides that form the 59 side of CTE loop B were
andomized in the context of a 1/2 CTE bearing the inactivating M2
utation. CTE variants that displayed significant b-gal activity in the
resence of VP16-Tap were then selected using the three hybrid screen
n yeast cells. The six recovered sequences, together with the number
f times each was recovered, are given at the top of the table as WT
nd the variants V1 to V5. Several CTE mutants (M2 to M5) were also
onstructed and are given in the lower part of the table. Relative
inding of these 1/2 CTE variants and mutants to full-length human Tap
as determined in yeast, as described in the legend of Table 1, and is
iven as a percentage of the activity of the wild-type 1/2 CTE averaged
ver several experiments. Variant V1 has previously been indepen-
ently reported as mutant #30, and mutant M4 as mutant #31, by
abernero et al. (1996), who reported both as partially active CTE
utants.
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203RNA BINDING SPECIFICITY OF HUMAN TapP16–Tap fusion protein (Table 2). Because the MS2-1/2
TE RNA is not capable of encoding a protein, this
elected RNA sequence, which differs from the 1/2 CTE
t only three locations, must presumably act by recruiting
n endogenously expressed yeast RNA binding protein
hat also contains a potent transcriptional activation do-
ain.
Because this randomization/selection screen led to
he recovery of only four CTE variants that retained the
bility to bind Tap, we generated three additional single
ucleotide mutants of the CTE, termed M3, M4, and M5
Fig. 1, Table 2), in order to confirm that other CTE point
utants would indeed show little or no Tap-binding ac-
ivity. This was particularly important for the M4 CTE
utant, as this mutant has been previously reported
Tabernero et al., 1996) to retain partial CTE function. In
act, as shown in Table 2, both the M4 and, to a lesser
xtent, the M5 CTE mutant did display a detectable level
f Tap binding that was, however, significantly lower than
he level of binding seen with any of the four recovered
TE variants. In contrast, the M3 point mutant, like the
ore extreme M2 CTE mutant that served as the tem-
late for the randomization/selection screen, proved un-
FIG. 2. Analysis of Tap binding to CTE variants in human cells. RNA b
93T cells were transfected with 500 ng of an HIV-1 LTR-based indic
ubstituted in place of TAR, together with 50 ng of a Tat or Tat–Tap fusio
nalyzed for HIV-1 LTR driven CAT expression levels at 48 h posttransfe
eviation.ble to bind Tap. mnalysis of CTE binding by tap in human cells
nd in vitro
To confirm the relevance of these yeast RNA binding
ata to the mammalian system, we next measured the
evel of Tap binding to each of these CTE mutants, in the
/2 CTE context, using a previously described mamma-
ian RNA:protein binding assay (Blair et al., 1998; Kang
nd Cullen, 1999). This assay is based on the ability of
he HIV-1 Tat protein to transcriptionally activate the
IV-1 long terminal repeat (LTR) promoter element when
ecruited either to the TAR element normally located in
he LTR or to a heterologous RNA target sequence sub-
tituted in place of TAR (Selby and Peterlin, 1990). We
ave previously shown (Kang and Cullen, 1999) that the
at:Tap fusion protein can potently activate an HIV-1 LTR
earing the 1/2 CTE sequence in place of TAR, and this
esult is reproduced in Fig. 2. As further demonstrated in
ig. 2, data obtained using this mammalian RNA:protein
inding assay was in excellent agreement with the yeast
hree hybrid assay for all CTE variants and mutants
ested with the exception of V4. Specifically, CTE variant
2 gave strong Tap binding, variants V1 and V3 gave
data were obtained using the Tat-based RNA:protein interaction assay.
smid, bearing the indicated wild-type or mutant form of the 1/2 CTE
in expression plasmid plus 1 mg of pBC12/CMV. Transfected cells were
verage of three independent transfections plus or minus the standardinding
ator pla
n prote
ction. Aodest binding, M4, and possibly M5, gave weak bind-
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204 KANG ET AL.ng, while mutants M2 and M3, as well as variants V4
nd V5, gave no detectable binding.
While the inability of the V5 CTE variant to bind Tap in
he mammalian nucleus was expected, given that the
iological activity of V5 in the yeast three-hybrid assay
as entirely independent of Tap (Table 2), the clear
iscrepancy between the yeast and mammalian binding
ssays in the case of V4 was surprising given the close
imilarity in the data recovered for all other CTE variants.
fter confirming the sequence integrity of the relevant
lones, we hypothesized that this difference might reflect
ither the presence of a facilitating yeast gene product or
he presence, in mammalian cells, of a gene product that
locks Tap binding to V4. To distinguish between these
wo possibilities, we used a competitive RNA gel shift
nalysis to compare binding by these various CTE vari-
nts in vitro. As shown in Fig. 3, and also previously
eported (Kang and Cullen, 1999), a recombinant protein
onsisting of residues 61 to 372 of Tap, which include the
ntire Tap RNA binding domain, fused to glutathione
-transferase (GST) is able to specifically bind to an RNA
robe consisting of the full-length CTE. To compare the
bility of the different CTE mutants and variants (Table 2)
o bind to Tap in vitro, we engineered each mutant or
ariant into both loops of the CTE and then transcribed
hese RNAs in vitro to generate unlabeled competitor
NAs. These were then added to the RNA:protein bind-
ng reaction at an ;200-fold molar excess over the la-
eled wild-type CTE probe. Binding of Tap by the added
nlabeled wild-type CTE competitor can specifically in-
FIG. 3. Tap binds the CTE specifically in vitro. The GST-Tap (6
hromatography. A full-length wild-type CTE probe was synthesized by
hen mixed with ;25 ng of the GST–Tap fusion protein in a 20-ml rea
onsisting of the indicated CTE mutations introduced into the full-lengt
he Tap:CTE binding reaction 10 min prior to addition of the labeled CT
esolved on a 5% native polyacrylamide gel and visualized by autorad
hen using the full-length wild-type CTE probe. The relative level of bin
inding, with binding in the absence of specific competitor set at 100%ibit binding by the labeled probe, and the level of re- tidual binding of the CTE probe is therefore a measure of
he relative affinity for Tap of each tested mutant CTE
ompetitor.
As shown in Fig. 3, addition of wild-type CTE compet-
tor entirely blocked probe binding (lane 3), while addi-
ion of a similar level of the inactive M2 CTE mutant had
ittle, if any, effect (lane 4). In addition, this in vitro assay
evealed strong competition for Tap binding by the V2
TE variant, significant competition by V1 and V3, and
ittle or no competition by V4 or by the CTE mutants M3,
4, and M5. We therefore conclude that the interaction
f V4 with Tap in yeast cells is likely to be an artifact that
s not reproduced either in vitro or in a mammalian
ell-based RNA binding assay. In contrast, binding of Tap
o the V1, V2, and V3 CTE variants and to the M2, M3, M4,
nd M5 CTE mutants was equivalent in all three assay
ormats.
he level of tap binding by CTE variants predicts
iological activity
A major rationale for generating the CTE variants
hown in Table 2 was to ask whether Tap-binding activity
ndeed correlated with CTE function in primate cells. The
DM128/CTE indicator plasmid, which encodes the cat
ndicator gene and wild-type CTE located between func-
ional 59 and 39 splice sites, has been previously de-
cribed (Hope et al., 1990; Bogerd et al., 1998). Because
plicing removes the cat open reading frame, efficient
AT expression is dependent on the nuclear export of
fusion protein was expressed in bacteria and purified by affinity
transcription in the presence of [a-32P]CTP and ;104 cpm (;0.1 ng)
ix containing 5 mg of nonspecific competitor RNA. Competitor RNAs,
were synthesized in vitro and added at an ;200-fold molar excess to
probe. After incubation at 4°C for 20 min, the reaction products were
y. C1 and C2 refers to the two distinct retarded complexes observed
s quantitated by Phosphorimager and is given as percentage residual1–372)
in vitro
ction m
h CTE,
E RNA
iograph
ding wahe unspliced cat mRNA, i.e., on CTE function. As shown
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205RNA BINDING SPECIFICITY OF HUMAN Tapn Fig. 4A and previously described elsewhere (Bogerd et
l., 1998; Kang and Cullen, 1999), the wild-type CTE
nduces a significant increase in the level of CAT expres-
ion in transfected human 293T cells relative to a plas-
FIG. 4. RNA export activity of the indicated CTE variants in human an
TE located between 59 and 39 splice sites. CAT expression is therefor
s inefficient in the absence of a functional cis-acting RNA export sig
utants, were analyzed in comparison to the wild-type CTE or to a for
hat therefore serves as a negative control. (A) Human 293T cells (35 m
5 ng of pBC12/CMV/b-gal, and 1 mg of pBC12/CMV as a carrier. Induc
uail QCl-3 cells (35 mm culture) were transfected with 25 ng of pBC12
00 ng of either the parental pBC12/CMV plasmid or pcTap plus 400 ng
AT activities determined. Both panels show the average of three in
eviation.id, termed pDM128/PL, that is identical except for the hack of a CTE. We therefore next constructed a set of
DM128/CTE derivatives bearing the CTE mutations de-
cribed in Table 2, introduced into both CTE loops, and
hen measured their biological activity in transfected
cells. The pDM128/CTE indicator construct contains the cat gene and
ndent on the nuclear export of an unspliced cat mRNA, a process that
ch as the CTE. pDM128/CTE variants, containing the indicated CTE
128 (pDM128/PL) that contains a poly-linker in place of the CTE and
ture) were transfected with 25 ng of the indicated pDM128 derivative,
T and b-gal activities were determined at ;48 h after transfection. (B)
-gal, 25 ng of the indicated pDM128/CTE based reported plasmid, and
12/CMV as filler. Cells were harvested at ;48 h after transfection and
dent transfection experiments plus or minus the indicated standardd quail
e depe
nal, su
m of DM
m cul
ed CA
/CMV/b
of pBC
depenuman cells. As shown in Fig. 4A, there was indeed a
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206 KANG ET AL.lose correlation between Tap-binding activity and CTE
iological activity. Specifically, we observed that the V2
nd M-L mutants displayed strong partial activity, while
he V1, V3, and possibly M4 CTE mutants displayed weak
ctivity. All other CTE mutants, including V4, proved to be
ssentially inactive.
Previously, we have demonstrated that the quail cell
ine QCl-3 is refractory to CTE function but is rendered
ully permissive upon transfection of a plasmid express-
ng the human Tap protein (Kang and Cullen, 1999). We
herefore next tested the biological activity of this same
et of CTE mutants and variants by transfection into
Cl-3 cells in the presence and absence of a cotrans-
ected Tap expression plasmid. As shown in Fig. 4B, the
uail cells, in the presence of Tap, gave a pattern of
iological activity that was qualitatively similar to, but
omewhat higher than, the level seen in human cells in
he absence of any cotransfected Tap (Fig. 4A). Specifi-
ally, CTE variant V2 and the M-L mutant were highly
ctive, variants V1 and V3 moderately active, and mutant
4 weakly active, while all other CTE mutants were
ssentially inactive.
DISCUSSION
The hypothesis that MPMV CTE-dependent nuclear
NA export is dependent on the specific and direct
ecruitment of the cellular Tap protein to the CTE is
upported by several observations. Thus, Tap has been
hown to bind the CTE specifically both in vitro and in
ivo and expression of human Tap has been shown to
nhance CTE function in Xenopus oocytes and to render
he otherwise nonpermissive quail cell line QCl-3 per-
issive for CTE function (Gru¨ter et al., 1998; Braun et al.,
999; Kang and Cullen, 1999). Finally, Tap has recently
een shown to contain a novel NES sequence that is
ritical for the activation of CTE function in QCl-3 cells
Kang and Cullen, 1999).
While the evidence supporting a role for Tap in medi-
ting CTE function is therefore increasingly persuasive,
he evidence supporting a role for Tap in mediating
lobal mRNA export is more circumstantial. Specifically,
t has been reported that injection of a high level of the
TE into the nucleus of Xenopus oocytes selectively
nhibits mRNA export but not other nuclear RNA export
athways (Pasquinelli et al., 1997; Saavedra et al., 1997).
his inhibition can be rescued by injection of recombi-
ant human Tap protein (Gru¨ter et al., 1998). In addition,
n the yeast system, the Mex67p protein, which appears
o be the yeast homolog of human Tap, has been shown
o be essential for mRNA export from the nucleus and to
e associated with bulk poly(A)1 RNA (Segref et al.,
997). Together, these observations suggest that Tap
ight play a sequence-specific role in the export of a
mall number of mRNAs that contain CTE-like elements
nd a sequence nonspecific role in global mRNA export. bow Tap would be recruited to mRNAs lacking a CTE is
ot presently apparent. In addition, direct recruitment of
ap to the CTE results in the nuclear export of unspliced
RNAs that are otherwise retained in the nucleus.
herefore, the nonspecific recruitment of Tap to mRNAs,
f it occurs, must either result in a different consequence
han specific recruitment or, alternately, may not normally
ccur until after the completion of RNA splicing.
In this manuscript, we have used a series of assays for
NA:protein binding in an attempt to characterize the
NA binding specificity of Tap, which contains a novel
eucine-rich RNA binding motif (Braun et al., 1999; Kang
nd Cullen, 1999). More specifically, we have used a
trategy of CTE RNA sequence randomization, followed
y selection for Tap binding in the yeast three hybrid
NA binding assay, to derive a set of CTE variants that
etain Tap binding ability. The purpose of this selection
as, first, to shed light on the target flexibility of the RNA
inding domain of Tap and, second, to derive a set of
TE variants with different affinities for Tap so that we
ould test whether this binding affinity is predictive of
TE function in vivo, as would be expected if Tap is
ndeed the Tap cofactor.
The strategy used was to randomize the seven nucle-
tides that form the critical 59 half of the loop B internal
TE loop (Fig. 1) and then to select RNAs from the
esultant library of 16,384 CTE variants, using the yeast
hree hybrid assay, that displayed readily detectable lev-
ls of b-gal activity in the presence of the VP16–Tap
usion protein. Perhaps surprisingly, this screen resulted
n the recovery of only five CTE sequence variants, in
ddition to the wild-type sequence, from this fairly exten-
ive library, and one of these sequences proved able to
nduce b-gal indicator enzyme entirely independently of
he VP16–Tap fusion and is therefore merely an interest-
ng artifact (Table 2).
To confirm that the CTE variants recovered in this
andomization/selection screen were indeed able to bind
o Tap, we also analyzed binding in mammalian cells and
n vitro. Unexpectedly, while the Tap binding ability of the
TE variants V1, V2, and V3, as well as of several addi-
ional CTE mutants, was similar in all three assays, the
4 CTE variant bound the Tap protein in yeast (Table 1)
ut not in either mammalian cells (Fig. 2) or in vitro (Fig.
). The reason for this discrepancy is unknown but must
resumably reflect the presence of a gene product in
east cells, that can mediate the specific recruitment of
P16-Tap to the V4 CTE variant, that is not present in the
ther two assay systems. Therefore, neither of the two
TE variants V4 and V5, that differ substantially in se-
uence from the CTE wild-type (Table 2) are, in fact,
enuine Tap binding sequences.
The remaining authentic Tap-binding CTE variants V1,
2, and V3, which each differ from the wild-type CTE
equence by only a single nucleotide, were next com-
ined with a small number of synthetic CTE mutants
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207RNA BINDING SPECIFICITY OF HUMAN TapM-L, M1, M3, M4, and M5) and then analyzed for bio-
ogical activity by transfection into the CTE-permissive
uman cell line 293T (Fig. 4A) or into QCl-3 cells in the
resence of a cotransfected human Tap expression plas-
id (Fig. 4B). These data demonstrate that (A) the Tap-
inding activity of these CTE variants and mutants mea-
ured in either mammalian cells (Fig. 2) or in vitro (Fig. 3)
s highly predictive of their biological activity in vivo and
B) the observed CTE activity in 293T cells in the absence
f cotransfected Tap is very similar to the biological
ctivity of these same CTE variants in QCl-3 cells in the
resence of cotransfected human Tap.
The data shown in Table 2 demonstrate that RNA
equence randomization followed by selection, in the
east three hybrid assay, of variants that retain protein
inding can indeed generate interesting information
bout the sequence specificity of an RNA:protein inter-
ction, and this technique may therefore have general
tility. Nevertheless, this approach did give rise to two
roblems. Specifically, while the V5 variant of the CTE,
hich gave strong b-gal activity even in the absence of
he VP16–Tap fusion protein, could be readily detected
nd eliminated from further consideration, the V4 variant
s disconcerting in that it specifically interacted with
P16–Tap in yeast cells (Table 2) yet was unable to bind
ap either in vitro (Fig. 3) or in mammalian cells (Fig. 2).
his observation suggests that RNA binding data ob-
ained in the yeast three hybrid system, like data ob-
ained in any other system, should preferably be con-
irmed using another assay. A second concern was that
he approach of identifying b-gal expressing yeast colo-
ies using an in situ assay for b-gal expression clearly
elected preferentially for high expressors (Table 2).
hus, the CTE wild type and the V5 variant, which each
xpress high levels of b-gal, were recovered 8 and 13
imes, respectively. In contrast, the V3 variant, which is
25% as active as wild type, was recovered only twice
hile mutant M4, which gives ;16% of the b-gal activity
f wild type, was not recovered at all. Therefore, while
he screen summarized in Table 2 almost certainly re-
overed all highly active CTE variants, additional CTE
ariants that retain only weak Tap binding are likely to
ave been missed. We note, however, that weak Tap
inding in the yeast three hybrid assay correlated with
oor CTE function in transfected vertebrate cells (Fig. 4).
In conclusion, we have demonstrated that the Tap
NA binding domain is highly sequence specific and that
TE variants that do retain the ability to bind Tap do so
ith reduced affinity when compared to wild type (Table
; Figs. 2 and 3). Thus, the CTE wild-type sequence is, in
act, the optimal RNA binding sequence for the human
ap protein. Second, we have demonstrated that Tap
inding affinity is highly predictive of the ability of CTE
ariants to support nuclear RNA export in not only human
ells but also in a quail cell line that only supports CTEunction when cotransfected with a human Tap expres- Rion plasmid (Fig. 4). Together, these data therefore fur-
her define the RNA sequence specificity of the novel
eucine-rich RNA binding domain in Tap and provide
dditional data supporting the identification of Tap as the
ofactor for MPMV CTE-dependent nuclear RNA export.
MATERIALS AND METHODS
lasmid construction
The following expression plasmids have been previ-
usly described: the mammalian expression plasmid
BC12/CMV, pcTat, pBC12/CMV/b-gal (Tiley et al., 1992);
cTat-Tap (Kang and Cullen, 1999); indicator constructs
ontaining the MPMV CTE (pDM128/CTE), or a polylinker
pDM128/PL) (Bogerd et al., 1998), in place of the CTE; a
eporter plasmid containing the cat indicator gene under
he control of the wild-type HIV-1 LTR (pTAR/CAT) (Tiley
t al., 1992) and an equivalent construct bearing the 1/2
TE (Fig. 1) in place of TAR (Kang and Cullen, 1999).
The yeast expression vector pVP16 has been de-
cribed (Bogerd et al., 1993). A triple HA tag was inserted
n frame to the VP16 coding sequence, into the BglII and
coRI sites of the polylinker sequence in pVP16, to gen-
rate the cloning vector pVP16-HA. Sequences encoding
ull-length Tap (Kang and Cullen, 1999) were inserted into
he EcoRI and XhoI sites of pVP16-HA to generated
lasmids expressing Tap proteins fused to the VP16
ranscription activation domain and the HA Tag. Full
ength and half CTE fragment were amplified by PCR and
hen inserted as blunt-ended DNA fragments into a SmaI
ite in the yeast plasmid pIII/MS2 (Sengupta et al., 1996)
o generated yeast three-hybrid plasmids that express
ybrid MS2-CTE RNAs under the control of the RNase P1
romoter. Mutations were introduced into pIII/MS2 de-
ivatives containing the complete or half CTE using the
uick change cite-directed mutagenesis kit (Stratagene).
DM128/CTE-based mutant/variant CTE indicator con-
tructs were generated by sequential mutagenesis of
oth internal loops of the CTE using the Quick change
ite-directed mutagenesis kit. Mutant or variant forms of
he CTE were PCR amplified from these pDM128/CTE-
ased plasmids and inserted into the BamHI site present
n the in vitro transcription plasmid pGEM-3fZ. 1/2 CTE
ragments were PCR amplified from pDM128/PL-based
TE constructs using primers containing unique BglII
nd SacI sites and inserted into pTAR/CAT digested with
he same enzymes to generate mutant/variant 1/2 CTE
onstructs for mammalian RNA-binding assay. The se-
uence of plasmids bearing mutant or variant CTEs was
onfirmed by DNA sequencing.
east three-hybrid assays
Saccharomyces cerevisiae L40-coat cells (Sengupta et
l., 1996) were transformed with a pIII/MS2-based hybrid
NA expression plasmid expressing wild-type or mutant
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208 KANG ET AL.orms of the CTE and with pVP16-HA-Tap. Transformants
ere selected on media lacking uracil and leucine. Over-
ight cultures of pooled transformants were suspended
n b-gal assay buffer, normalized to optical density, and
-gal activities assayed as previously described (Bogerd
t al., 1993).
n vivo randomization/selection of tap binding
equences
The randomized half CTE library was generated by
arge scale site-directed mutagenesis of the mutant half-
TE yeast three-hybrid construct pIII/MS2/1/2CTE-M2
sing the following primers with randomized sequence
rom nucleotide 8070 to 8076 of the MPMV CTE:
9-CCCCCGGATCCACTAACCNNNNNNNGGAGGGC-
GTCAAAGCTA-39 and 59-TAGCTTTGACGGCCCTCC-
NNNNNNGGTTAGTGGATCCGGGGG-39. The mutagen-
sis products were transformed into Escherichia coli
H5a. After selection for ampicillin-resistant transfor-
ants, the randomized library was found to consist of
bout 50,000 independent clones. DNA from the library
as pooled and cotransformed with pVP16-HA-Tap into
east L40 coat cells. The transformed yeast cells were
lated on uracil- and leucine-deficient (Ura2Leu2) plates
overed with a Hybond-N nylon membrane (Amersham).
n in situ b-gal assay was carried out essentially as
reviously described (Kang and Cullen, 1998). After 3
ays of growth, the nylon membrane with yeast colonies
as lifted from the plate, frozen at 140°C for 10 min and
hen thawed at room temperature. The nylon membrane
as placed on filter papers soaked in 0.5 3 Z buffer
Blair et al., 1994) with 0.3 mg of chlorophenolred-D-
alactopyranoside (CPRG; Boehringer-Mannheim) per
illiliter and 0.1% (vol/vol) 2-mercaptoethanol. After 1 h of
ncubation at room temperature, colonies that turned
lue were picked and recovered on Leu2 Ura2 plates,
nd the yeast indicator plasmids harboring candidate
ap binding site variant sequences rescued after over-
ight culture. A second yeast transformation and b-gal
ssay were then performed with the selected indicator
lasmids, together with either pVP16-HA-Tap or the pa-
ental plasmid pVP16, to quantify the level of transacti-
ation by Tap and to identify any false-positive clones.
he CTE sequences in the true-positive clones were
hen obtained by ABI automatic cycle sequencing (PE
pplied Biosystems).
ell culture and transfection
Human 293T and quail QCl-3 were maintained as
reviously described (Cullen et al., 1983; Bogerd et al.,
998) and transfected using lipofectamine (Life Technol-
gies) or DEAE-Dextran (Cullen et al., 1983), respectively.
ll transfections were performed on cell cultures in
5-mm plates. Levels of DNA used in each transfection
xperiment are given in the relevant figure legend, with BBC12/CMV/b-gal included as an internal control. In all
ransfection experiments, CAT enzyme levels were de-
ermined 48 h after transfection, as previously described,
nd normalized to the level of b-gal activity present in the
ell lysate (Bogerd et al., 1998).
el shift analysis
A GST-fusion protein, containing the RNA binding do-
ain (aa 61–372) of Tap, was expressed and purified on
lutathione affinity resin as previously described (Kang
nd Cullen, 1999). The wild-type CTE RNA probe was
abeled with [a-32P]CTP using the Riboprobe in vitro
ranscription system (Promega) and the total isotope
ncorporation determined by scintillation counting after
olumn purification. Unlabeled competitor RNAs were
ynthesized using the RiboMax large scale RNA produc-
ion system (Promega). The binding reaction was carried
ut with ;104 cpm (;0.1 ng) of the probe and 25 ng of
ST–Tap fusion protein in 20 ml of binding buffer (150
M KCl, 10 mM Hepes (pH 7.6), 0.5 mM EGTA, 2 mM
gCl2, 1 mM DTT, and 10% glycerol) containing 4 mg of
RNA and 1 mg of yeast tRNA. Competitor RNAs were
dded at a 200-fold molar excess over the labeled probe
ragment and incubated with GST–Tap (61–372) for 10
in before addition of the probe. Binding was allowed to
roceed for 20 min at 4°C and the reaction products
esolved on a 5% (40:1) native polyacrylamide gel and
isualized by autoradiography. The results of competition
xperiments were quantitated with a PhosporImager and
mage QuaNT software (Molecular Dynamics).
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